Onderneming Mirna Therapeutics Inc Nasdaq
Aandelen
US60470J1034
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Synthetic Biology Therapeutics
100,0
%
| 1 | 100,0 % | 3 | 100,0 % | +185,68% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 3 | 100,0 % | +185,68% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mary Dooley
DFI | Director of Finance/CFO | 43 | 01-06-18 |
Caroline Kurtz
PRN | Corporate Officer/Principal | - | 01-10-16 |
Brendan St Amant
LAW | General Counsel | - | 01-07-21 |
Thomas J. Adam
HRO | Human Resources Officer | - | 28-08-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Shea
BRD | Director/Board Member | 72 | 28-08-17 |
Peter Barrett
CHM | Chairman | 71 | 28-08-17 |
Director/Board Member | 64 | 01-10-12 | |
Director/Board Member | 59 | 08-12-20 | |
Nick Leschly
BRD | Director/Board Member | 51 | 28-08-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 986 803 | 9 884 522 ( 82,46 %) | 279 792 ( 2,334 %) | 82,46 % |
Bedrijfsgegevens
![Adres Mirna Therapeutics Inc](https://cdn.zonebourse.com/static/address/23894470.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |